Drug-related research is crucial to understanding Europe’s drug problems. Drug-related research enables Europe to learn lessons from the past and sharpens Europe’s awareness and monitoring of the present. Research also helps Europe to prepare for the future, by looking at issues such as resource allocation, best practices, and the piloting of innovative approaches to managing problem drug use. In short, science and research enable policymakers to better understand the multiple facets of drug use as it affects both the individual and society.
An update on the EMCDDA 2008 Selected Issue on drug-related research, this thematic paper identifies current and future challenges/opportunities for drug-related research in Europe.
This online resource — specifically developed for researchers — offers information on drug-related research resources in Member States, in the European Union and at the EMCDDA.
This Selected issue provides an overview of the framework within which drug-related research is carried out in European countries. It focuses on a number of topics, including: the role of drug-related research at national level; coordination and funding arrangements; research and dissemination structures; as well as major recent research projects. The publication is a summary of the available information from national focal points and other sources, including the EMCDDA's stakeholders such as its Scientific Committee, expert groups, the European Commission, and the Centre's staff. A multilingual summary of the contents is also available.
Country overviews provide a structured synopsis of the trends and characteristics of the drug situation in each country, including a summary of the drug-related research in the country. They are updated once a year.
This publication offers a comprehensive overview of qualitative research in the EU. Focusing on the meanings, perceptions, processes and contexts of the ‘world of drugs’, the value of qualitative research is to complement quantitative data and analyses and provide insight into developments behind the statistics. In over 40 chapters, the monograph highlights the multiple roles, techniques and methods of qualitative research, as well as its impact on policymaking.
In 1996, representatives of the 15 Member States and individual researchers were invited to a joint seminar, organised by the European Commission and the EMCDDA, entitled ‘Drug research-related initiatives in the European Union’. The seminar was held under the European Commission’s project Inventing tomorrow which aimed to propose guidelines for the Fifth research and technical development framework programme. National focal points were requested by the European Commission Drugs Coordination Unit and the EMCDDA to prepare ‘national reports on the national drug research situation and identification of research needs.' The results of this initiative are presented in this report.